Actively Recruiting
Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
Led by National Geriatric Hospital · Updated on 2026-04-09
80
Participants Needed
2
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Frailty is common among older patients with chronic obstructive pulmonary disease (COPD) and is associated with poor functional outcomes and increased health risks. This study aims to determine the prevalence of frailty and to evaluate the effects of the Vivifrail exercise program on physical performance, activities of daily living, and quality of life in older COPD patients at Hospital 198, Ministry of Public Security, Vietnam.
CONDITIONS
Official Title
Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 260 years
- Diagnosis of COPD according to GOLD criteria
- Clinically stable COPD with no exacerbation within the past 4 weeks
- Ability to participate in exercise training
- Provide informed consent
You will not qualify if you...
- Acute COPD exacerbation within the past 4 weeks
- Severe cardiovascular disease limiting exercise
- Severe cognitive impairment
- Musculoskeletal disorders preventing exercise
- Participation in another clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital 198, Ministry of Public Security
Hanoi, Hanoi, Vietnam
Actively Recruiting
2
Hospital 198, Ministry of Public Security
Hanoi, Vietnam
Actively Recruiting
Research Team
D
Diu Thi Vu, MD, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here